降低心血管风险的一氧化氮供体型罗格列酮衍生物的设计、合成与生物活性研究

来源 :全国药物化学学术会议暨第四届中英药物化学学术会议 | 被引量 : 0次 | 上传用户:hjjcumt
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
其他文献
会议
会议
Microtubules—key components of the cytoskeleton —are crucial in the development and maintenance of cell shape,transport of vesicles,mitochondria and other components throughout cells,in cell signaling
A series of novel quinoline and 1,2-dihydroquinoline derivatives connected by a 4-oxy-3-fluoroaniline moiety were synthesized,and evaluated for their c-Met kinase inhibitory activity and antiprolifera
An efficient,one-pot synthesis of 4-methylisoquinolines via a cascade Pd-catalyzed Heck reaction,intramolecular cyclization and isomerization has been developed.
会议
Idiopathic pulmonary fibrosis(IPF)is commonly considered the result of a recurrent injury to the alveolar epithelium followed by an uncontrolled proliferation of fibroblasts.Currently,there is no effi
Salification is most commonly employed for modifying physical and chemical properties.However,there are few reports about the differences in biological activity between different salt forms and free a
肿瘤多药耐药(MDR)是指肿瘤细胞对一种药物出现耐药性后,对其他化学结构和作用机制不同的药物产生交叉耐药性[1]。肿瘤的多药耐药形成机制有多种,其中研究最深入也是最重要的一种机制为ABC(ATP-Binding Cassette)超家族膜蛋白介导的药物外排泵的过表达。
目的 阿尔茨海默症(AD)是一种复杂的中枢神经系统退行性疾病,目前全球患者已超过3600万。临床上用于治疗AD的药物只有5个,均属于单靶点抑制剂。这类药物只能缓解AD 的症状,不能从根本上改善疾病状态或终止疾病进程。